<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04306406</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0004</org_study_id>
    <nct_id>NCT04306406</nct_id>
  </id_info>
  <brief_title>Molecular Mechanisms of Raspberries Effect on Insulin Resistance and Inflammation</brief_title>
  <acronym>RASPBERRY</acronym>
  <official_title>Molecular Mechanisms Underlying the Protective Effects of Whole Red Raspberries Against Insulin Resistance and Inflammation in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Processed Raspberry Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Louisiana State University and A&amp;M College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Red raspberries (Rubus idaeus) are a good source of health enhancing hydrolyzable and
      condensed tannins, flavonoids, anthocyanins, phenolic acids, rheosmin, potassium,
      carotenoids, vitamin C, and vitamin K1. Compared to other berries commonly consumed in the
      US, the health benefits of red raspberries to improve pre-diabetes mellitus (PDM) and type 2
      diabetes have never been explored. The clinical study proposed in this project seeks to
      investigate the protective effect of whole red raspberries against insulin resistance,
      oxidative stress, and inflammation in PDM and type 2 diabetic patients. The in vitro study
      proposed in the project will assist in identifying the molecular mechanisms by which whole
      red raspberry protect islet cells against oxidative stress, insulin resistance and loss of
      cell function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2015</start_date>
  <completion_date type="Actual">January 13, 2017</completion_date>
  <primary_completion_date type="Actual">January 13, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Ratio of fasting insulin and glucose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A high-sensitivity C-reactive protein (hs-CRP) measured in milligrams per liter</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measure of systemic inflammation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>3,4-Dihydroxyphenylacetic acid (DOPAC) measured in nanograms per milliliter</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measure of systemic inflammation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Inflammation</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Raspberry Smoothies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single serving smoothies drink made with red raspberries to be consumed daily for two weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Raspberries</intervention_name>
    <description>Red raspberry smoothies drink</description>
    <arm_group_label>Raspberry Smoothies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 2 diabetes

        Exclusion Criteria:

          -  hypoglycemic agents

          -  Pregnant or nursing a child

          -  chronic medication that does not have a stable dose for greater than one month

          -  anti-inflammatory medication

          -  inflammatory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank L Greenway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Frank Greenway</investigator_full_name>
    <investigator_title>Professor; Chief Medical Officer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Excel spreadsheets containing clinical trial data can be made available to other researchers after publication of research results.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will become available after publication of research results.</ipd_time_frame>
    <ipd_access_criteria>Academic researcher</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

